Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
6
self-reported 2–10 band
Founded
Not recorded
Legal entities
1
ABR
Office countries
1
1 address
Funding rounds
2
Grant · Jul 2025 · US$ 968.2K
Company type
Privately Held
self-reported
Legal entity
1 brand → 1 confirmed entity
INOSI THERAPEUTICS PTY LTD
ABN62630651464
Legal entities
Show as table · Inosi Therapeutics Pty Ltd: 1 registry entity
| INOSI THERAPEUTICS PTY LTD | ABN 62630651464 |
|---|---|
| Confirmed matches | 0 of 1 |
A candidate is a name match on the registry, not a confirmed identity, and two candidates are ambiguity rather than a corporate structure.
Description
Inosi Therapeutics tackles fibrosis.
Inosi Therapeutics, a company based on research at Monash University, has launched with an investment from IP Group and BioCurate.
The company has been founded to develop therapies to address fibrosis, a condition associated with many chronic diseases where tissue damage leads to scarring and a loss of organ function. Inosi recognises the importance of close and early engagement between academic researchers and industry partners to ensure new therapy development programs are informed and aligned with addressing unmet patient and market needs.
Inosi’s technology is based on collaborative research from a team at Monash University led by Assoc Professor Siew Chai, Dr Tracey Gaspari, Professor Robert Widdop from Monash Biomedicine Discovery Institute and Professor Philip Thompson from the Monash Institute of Pharmaceutical Sciences, with Monash Innovation leading the deal. The drug development program originated from a collaboration with St Vincent’s Institute of Medical Research and the Florey Institute of Neuroscience and Mental Health, both University of Melbourne affiliates, and since progressed with the fibrosis group at Monash.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUMelbourne, VIC 3006Primary
Grid intelligence Members
Funding
Rounds2
Round typeGrant · non-equity funding
Amount (USD)968,200
Stage rank1
Investors named1
Since last round6 mo
Funding
Show as table · 2 funding rounds
| Rounds | 2 |
|---|---|
| Axis | 2025 to 2027 |
| Grant · 20 Jul 2025 | US$ 968.2K |
Dated rounds only. The axis ends at the date this profile was last observed, not at today.
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
People & contacts
3 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
The people relation is never requested, so there is nothing here to unlock.
FAQ
Which legal entity operates under Inosi Therapeutics Pty Ltd?
One Victoria entity on the ABR: INOSI THERAPEUTICS PTY LTD (ABN 62 630 651 464), high confidence.
How many people work at Inosi Therapeutics Pty Ltd?
6 counted staff profiles at January 2026, inside the self-reported 2–10 band.
Where does Inosi Therapeutics Pty Ltd have offices?
One address on record, Australia only. Primary: Melbourne, VIC 3006.
Has Inosi Therapeutics Pty Ltd raised funding?
Two rounds. Latest 20 July 2025: grant, US$968,200, investor MTPConnect.
Which companies are listed alongside Inosi Therapeutics Pty Ltd?
24 profiles list Inosi Therapeutics Pty Ltd as a peer — 96th percentile in Pharmaceutical Manufacturing. It lists ten peers of its own. Immunosis and Rage Bio list it back.